Yatharth Hospital & Trauma Care Services: Business Overview & Financial Analysis
Yatharth Hospital is a leading super-specialty healthcare provider in North India, headquartered in Noida, Uttar Pradesh. Promoted by Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar Tyagi, the enterprise operates tertiary care hospitals across Delhi-NCR and Madhya Pradesh. Operating multi-specialty facilities in Noida, Greater Noida, Noida Extension, Faridabad, New Delhi (Model Town), Jhansi, Agra, and Gurugram, Yatharth Hospital delivers advanced cardiac care, oncology, neurosciences, nephrology, and trauma care services.
Key Financial Highlights of Yatharth Hospital (Q1 FY2027)
Yatharth Hospital recorded strong top-line turnover expansion during the first quarter of FY2027, driven by rapid capacity ramp-ups across newly commissioned healthcare facilities.
- Consolidated Operating Revenue – Rs 392.65 crore (+51.5% YoY vs Rs 257.77 crore in Q1 FY2026)
- Consolidated Operating EBITDA – Rs 91.70 crore (+39.1% YoY vs Rs 65.92 crore in Q1 FY2026)
- Operating EBITDA Margin Realisation – 23.35% (-167 bps YoY)
- Consolidated Net Profit After Tax (PAT) – Rs 47.06 crore (+11.9% YoY vs Rs 42.04 crore in Q1 FY2026)
- Revenue Contribution from New Hospitals – 27.0% of Total Revenue (Rs 106.70 crore)
First-quarter revenue expanded 51.5% year-on-year to Rs 392.65 crore as new hospitals in Faridabad, Model Town, and Agra scaled operations. Operating EBITDA margins held at 23.35%, absorbing short-term gestation costs from fresh bed additions.
Hospital Portfolio & Bed Network Scale of Yatharth Hospital (Q1 FY2027)
Yatharth Hospital manages an expanding network of super-specialty units strategically positioned across high-density urban catchments in North India.
- Operational Census Beds Base – 1,820 active beds (Up from 1,645 beds in Q4 FY2026)
- Total Network Capacity Base – 2,800+ total beds across 9 operational and pipeline hospitals
- Noida Cluster Bed Capacity – 1,100 operational beds across 3 hospitals (+450 upcoming beds)
- Faridabad Cluster Bed Capacity – 600 operational beds across 2 hospitals (Sector-20 and Greater Faridabad)
- New Delhi Model Town Unit Scale – 300 operational beds in high-value North Delhi catchment
- Agra Facility Capacity Scale – 250 operational beds delivering >20% operating EBITDA margins
- Gurugram Sector-40 Project (Acquired June 2026) – 250 upcoming beds targeted for Q1 FY2028 commissioning
Operating 1,820 census beds across NCR and regional hubs establishes regional brand dominance. Acquiring the 250-bed Gurugram Sector-40 project expands presence into high-ARPOB corporate corridors.
Key Operational KPIs of Yatharth Hospital (Q1 FY2027)
Yatharth Hospital tracks operational throughput metrics including occupancy levels, average revenue per occupied bed, and patient length of stay across its hospitals.
- Average Revenue Per Occupied Bed (ARPOB) – Rs 34,758 per day (+7.3% YoY vs Rs 32,395)
- Premium Facilities ARPOB Realisation – ~Rs 50,000 per day (New Delhi Model Town and Noida Extension)
- Operational Bed Occupancy Rate – 68.0% (vs 65.0% in Q1 FY2026)
- Average Length of Stay (ALOS) – 3.7 days (Compressed from 4.1 days in Q1 FY2026)
- Monthly Revenue Run-Rate (Faridabad Sector-20) – Rs 12.0 to Rs 13.0 crore per month
ARPOB expanded 7.3% year-on-year to Rs 34,758 per day, while bed occupancy reached 68%. Compressing the average length of stay to 3.7 days accelerates bed turnover and patient throughput.
Speciality & Revenue Mix of Yatharth Hospital (FY2026)
Yatharth Hospital structures its clinical turnover across advanced super-specialty departments, oncology care, complex surgeries, and diagnostic procedures.
- Cardiology & Cardiac Sciences Share – 26.0% of Total Clinical Revenue
- Neurosciences & Orthopaedics Share – 22.0% of Total Clinical Revenue
- Nephrology, Urology & GI Sciences Share – 18.0% of Total Clinical Revenue
- Oncology & Radiation Therapy Share – 10.0% of Total Clinical Revenue (Targeting 15% mix)
- Internal Medicine & General Surgery Share – 24.0% of Total Clinical Revenue
- Cash & TPA Patient Payor Mix (New Facilities) – >90.0% cash and private insurance mix
Cardiology and neurosciences generate nearly half of overall clinical revenues, supported by advanced surgical suites. Higher private insurance and cash payor contributions above 90% in new units accelerate cash collection velocity.
Consolidated Annual Financial Performance of Yatharth Hospital (FY2026)
Yatharth Hospital delivered full-year turnover expansion and bottom-line earnings growth for full financial year FY2026.
- Full Year Consolidated Revenue from Operations – Rs 1,232.96 crore (+22.0% YoY)
- Full Year Consolidated Operating EBITDA – Rs 302.10 crore (+24.0% YoY)
- Full Year Operating EBITDA Margin – 24.50% (+41 bps YoY)
- Full Year Consolidated Net Profit After Tax (PAT) – Rs 170.30 crore (+38.0% YoY)
- Full Year Return on Capital Employed (ROCE) – 22.50%
Full-year operating turnover crossed Rs 1,230 crore in FY2026, as consolidated Net Profit After Tax surged 38.0% to Rs 170.30 crore. Financial execution was supported by inpatient volume growth and capacity scaling across Greater Noida and Faridabad.
Balance Sheet Structure & Financial Health of Yatharth Hospital (Q1 FY2027)
Yatharth Hospital operates a net-cash capital structure supported by equity proceeds, high operating cash flow conversion, and disciplined working capital.
- Financial Debt Status – Net-Cash Positive / Low Debt Gearing
- Total Surplus Cash & Treasury Reserves – >Rs 300.00 crore
- Total Consolidated Net Worth Base – ~Rs 1,250.00 crore
- Trade Receivables Collection Period – 123 days (Targeting compression to 115 days)
- Promoter Group Shareholding Share – 55.8% (Dr. Tyagi family)
The enterprise closed Q1 FY2027 with a net-cash balance sheet backed by over Rs 300 crore in treasury reserves. Maintaining zero net financial debt provides flexibility to fund brownfield hospital expansions without borrowing.
Capex Outlay & Expansion Roadmap of Yatharth Hospital (FY2027–FY2028)
Yatharth Hospital executes capital allocation plans to construct greenfield hospitals, expand existing bed counts, and install radiation oncology equipment.
- Planned Multi-Year Capex Outlay – Rs 1,400 to Rs 1,500 crore across FY2027–FY2029
- Gurugram Sector-40 Acquisition & Setup Investment – Rs 200.00 crore total outlay (Rs 100 crore acquisition + Rs 100 crore capex)
- Noida Extension & Greater Noida Brownfield Expansion – Adding 450 beds across existing campuses
- Target Operational Bed Scale – 3,500+ operational beds by FY2028
- Funding Strategy – 100% funded through internal cash accruals and liquid surplus reserves
Capital expenditure of Rs 1,400–1,500 crore over three years will scale total operational capacity past 3,500 beds. Internal operational cash flows and cash reserves fully fund the Gurugram setup and Noida brownfield additions.
Management Commentary & Future Outlook of Yatharth Hospital (Q1 FY2027)
Management guidance outlines strategic priorities centered on top-line revenue acceleration, ARPOB expansion, and cluster market leadership in North India.
- Management targets achieving a 30%+ top-line revenue CAGR over full financial year FY2027.
- Consolidated operating EBITDA margins are guided to sustain around the 24.0%–25.0% corridor as new hospitals breakeven.
- Average Revenue Per Occupied Bed (ARPOB) is projected to reach Rs 36,000–38,000 per day driven by Model Town and Gurugram.
- Faridabad Sector-20 and Model Town hospitals are expected to achieve full operating EBITDA breakeven in H2 FY2027.
- Oncology revenue share is targeted to scale from 10% toward 15% over the next two years.
- Capital allocation strategy will prioritize maintaining a net-cash balance sheet while expanding in major metro clusters.
Management anticipates strong demand for super-specialty healthcare and oncology treatments to drive bed occupancy. Operational focus centers on commissioning the Gurugram hospital by Q1 FY28, scaling high-ARPOB specialties, and preserving balance sheet health.
Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.
Sources & References
- Yatharth Hospital Q1 FY2027 Consolidated Financial Results Disclosures & Media Release (August 10/11, 2026)
- Yatharth Hospital Q1 FY2027 Earnings Call Transcript & Slide Presentation (August 10/11, 2026)
- Yatharth Hospital Corporate Announcements & Regulatory Stock Exchange Outcomes
- BSE Limited & National Stock Exchange of India (NSE) Corporate Filings for Yatharth Hospital
- Ticker Finology Yatharth Hospital Page
Disclaimer
The information presented above on Yatharth Hospital & Trauma Care Services has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Yatharth Hospital & Trauma Care Services page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.